Status
Acquired by AstraZeneca on August 26, 2013
Funding Received
$20 Million in 1 Round from 2 Investors
Headquarters:
Rockville, MD
Description:
Amplimmune is a product-driven company offering immune-based biologics to treat patients with cancer, autoimmunity, and infectious diseases.
Categories:
Health and Wellness, Medical, Pharmaceuticals, Biotechnology
Website:
http://www.amplimmune.com

Detailed Description

Update

Amplimmune is a product driven company that is developing immune-based biologics to treat patients in the areas of cancer, autoimmunity, transplantation and infectious diseases. Amplimmune's scientific founders from Johns Hopkins University have identified several key immunological ligands and receptors. These immunological checkpoint and co-stimulatory molecules are the basis for developing a new class of biological treatments which modulate critical mechanisms in the body's immune system with the aim of bettering the lives of patients suffering from aberrant immunological conditions.

Current Team (4)

Update

Funding Rounds (1) - $20M

Update

Board Members and Advisors (1)

Update

Investors (2)

Update
  • Bb3d6fbd0e442789b59061f392f8ad0d

    InterWest Partners

    InterWest invests an average of about $7 - 15 million over the span of their involvement with...
  • 71973821ab4a99d43b2cf5b134b0d731

    Wellcome Trust

    Wellcome Trust is a UK-based medical research charity that funds research with the ultimate aim...

Offices/Locations (1)

Update
  • Office

    9800 Medical Center Drive

    Suite C-120

    Rockville, MD 20850

    USA

Images (1)

Update
  • 7f2dad9aa991064840529673f81d3ba4